Related references
Note: Only part of the references are listed.Self-Adjuvanting Polymer-Peptide Conjugates As Therapeutic Vaccine Candidates against Cervical Cancer
Tzu-Yu Liu et al.
BIOMACROMOLECULES (2013)
Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine
Xiaosong Li et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Vaccination induced antibodies to recombinant avian influenza A virus M2 protein or synthetic M2e peptide do not bind to the M2 protein on the virus or virus infected cells
Willem J. C. Swinkels et al.
VIROLOGY JOURNAL (2013)
M-Protein-derived Conformational Peptide Epitope Vaccine Candidate against Group A Streptococcus
Mariusz Skwarczynski et al.
CURRENT DRUG DELIVERY (2013)
Intranasal immunization with a flagellin-adjuvanted peptide anticancer vaccine prevents tumor development by enhancing specific cytotoxic T lymphocyte response in a mouse model
Chung Truong Nguyen et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2013)
Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope
Jai S. Rudra et al.
BIOMATERIALS (2012)
Advances in Peptide-based Human Papillomavirus Therapeutic Vaccines
Tzu-Yu Liu et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion
Nathalie Garcon et al.
EXPERT REVIEW OF VACCINES (2012)
PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses
Wenxue Ma et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Monovalent ligands that trigger TLR-4 and TCR are not necessarily truly monovalent
Alexander B. Sigalov
MOLECULAR IMMUNOLOGY (2012)
Liposome-based delivery system for vaccine candidates: constructing an effective formulation
Ashwin Kumar Giddam et al.
NANOMEDICINE (2012)
Immunological Evaluation of Lipopeptide Group A Streptococcus (GAS) Vaccine: Structure-Activity Relationship
Mehfuz Zaman et al.
PLOS ONE (2012)
Peptide-Based Subunit Vaccine against Hookworm Infection
Mariusz Skwarczynski et al.
PLOS ONE (2012)
The mechanism of action of MF59 - An innately attractive adjuvant formulation
D. T. O'Hagan et al.
VACCINE (2012)
Cross-presentation by dendritic cells
Olivier P. Joffre et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Antitumor activity of liposomal ErbB2/HER2 epitope peptide-based vaccine constructs incorporating TLR agonists and mannose receptor targeting
Jean-Sebastien Thomann et al.
BIOMATERIALS (2011)
Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles
Yoshio Fujita et al.
CHEMISTRY CENTRAL JOURNAL (2011)
CpG DNA as a vaccine adjuvant
Christian Bode et al.
EXPERT REVIEW OF VACCINES (2011)
ISCOMATRIX Adjuvant Combines Immune Activation with Antigen Delivery to Dendritic Cells In Vivo Leading to Effective Cross-Priming of CD8+ T Cells
Peter Duewell et al.
JOURNAL OF IMMUNOLOGY (2011)
Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine
Mehfuz Zaman et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
DNA released from dying host cells mediates aluminum adjuvant activity
Thomas Marichal et al.
NATURE MEDICINE (2011)
Peptide-Based Subunit Nanovaccines
Mariusz Skwarczynski et al.
CURRENT DRUG DELIVERY (2011)
Polyacrylate Dendrimer Nanoparticles: A Self-Adjuvanting Vaccine Delivery System
Mariusz Skwarczynski et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles
Sharmila Pejawar-Gaddy et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination
Kanako Iseki et al.
CANCER SCIENCE (2010)
Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides
Elena Mata et al.
DRUG DELIVERY (2010)
Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists
Matthew Black et al.
EXPERT REVIEW OF VACCINES (2010)
T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection
Karen Smith Korsholm et al.
IMMUNOLOGY (2010)
Immunization with Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, but Causes Sterile Abscesses and Unacceptable Reactogenicity
Barney S. Graham et al.
PLOS ONE (2010)
A self-assembling peptide acting as an immune adjuvant
Jai S. Rudra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Structure-activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2
Mehfuz Zaman et al.
VACCINE (2010)
Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trial
Francois Roman et al.
VACCINE (2010)
Two novel HLA-A*0201 T-cell epitopes in avian H5N1 viral nucleoprotein induced specific immune responses in HHD mice
Ying-Kit Cheung et al.
VETERINARY RESEARCH (2010)
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Joerg Vollmer et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Lipid Core Peptide System for Gene, Drug, and Vaccine Delivery
Wei Zhong et al.
AUSTRALIAN JOURNAL OF CHEMISTRY (2009)
Co-assembling peptides as defined matrices for endothelial cells
Jangwook P. Jung et al.
BIOMATERIALS (2009)
Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy
Joseph R. Podojil et al.
IMMUNOLOGICAL REVIEWS (2009)
Chitosan formulations improve the immunogenicity of a GnRH-I peptide-based vaccine
Leonardo Saenz et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
A Simple Mycobacterial Monomycolated Glycerol Lipid Has Potent Immunostimulatory Activity
Claire S. Andersen et al.
JOURNAL OF IMMUNOLOGY (2009)
A Nonadjuvanted Polypeptide Nanoparticle Vaccine Confers Long-Lasting Protection against Rodent Malaria
Stephen A. Kaba et al.
JOURNAL OF IMMUNOLOGY (2009)
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
Fiona A. Sharp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response
Marija Brgles et al.
VACCINE (2009)
Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection
Jamie F. S. Mann et al.
VACCINE (2009)
Novel immunoadjuvants based on cationic lipid: Preparation, characterization and activity in vivo
Nilton Lincopan et al.
VACCINE (2009)
Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice
Satoshi Ohno et al.
VACCINE (2009)
A universal epitope-based influenza vaccine and its efficacy against H5N1
Y. Adar et al.
VACCINE (2009)
The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization
Hu-Lin Jiang et al.
BIOMATERIALS (2008)
Self-adjuvanting lipopeptide vaccines
Peter M. Moyle et al.
CURRENT MEDICINAL CHEMISTRY (2008)
DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4
Tetsuya Tanaka et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1β secretion but dispensable for adjuvant activity
Luigi Franchi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Vitamin E ingestion improves several immune functions in elderly men and women
Monica De la Fuente et al.
FREE RADICAL RESEARCH (2008)
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
Mirjam Kool et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Stephanie C. Eisenbarth et al.
NATURE (2008)
Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2
Lilian O. Moreira et al.
VACCINE (2008)
A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection
Brendon Y. Chua et al.
VACCINE (2008)
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice
Andreas Wack et al.
VACCINE (2008)
A Virosomal Malaria Peptide Vaccine Elicits a Long-Lasting Sporozoite-Inhibitory Antibody Response in a Phase 1a Clinical Trial
Shinji L. Okitsu et al.
PLOS ONE (2007)
Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response
Vibhu Kanchan et al.
BIOMATERIALS (2007)
A Randomized Placebo-Controlled Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Synthetic Peptides in Healthy Adult Volunteers
Blaise Genton et al.
PLOS ONE (2007)
MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection
Derek T. O'Hagan
EXPERT REVIEW OF VACCINES (2007)
Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation
Stanley L. Hem et al.
EXPERT REVIEW OF VACCINES (2007)
Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines
Peter M. Moyle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The perfect mix: recent progress in adjuvant research
Bruno Guy
NATURE REVIEWS MICROBIOLOGY (2007)
Evidence for correlation between the intensities of adjuvant effects and NOD2 activation by monomeric, dimeric and lipophylic derivatives of N-acetylglucosaminy N-acetylmuramyl peptides
Elena Meshcheryakova et al.
VACCINE (2007)
The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes
Karen Smith Korsholm et al.
IMMUNOLOGY (2007)
Virosome-mediated delivery of tumor antigen to plasmacytoid dendritic cells
Juliette Angel et al.
VACCINE (2007)
Monophosphoryl lipid A analogues with varying 3-O-substitution: synthesis and potent adjuvant activity
Zi-Hua Jiang et al.
CARBOHYDRATE RESEARCH (2007)
More than one reason to rethink the use of peptides in vaccine design
Anthony W. Purcell et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Immunodominant peptides from conserved influenza proteins - A tool for more efficient vaccination in the elderly?
Giovanni Almanzar et al.
WIENER MEDIZINISCHE WOCHENSCHRIFT (2007)
Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants
Ilia Z. Romero Mendez et al.
VACCINE (2007)
Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccine
Chengji Cui et al.
VACCINE (2007)
Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines
Yuk Fai Lau et al.
INTERNATIONAL IMMUNOLOGY (2006)
Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease
Michael R. Batzloff et al.
IMMUNOLOGIC RESEARCH (2006)
Toll-dependent selection of microbial antigens for presentation by dendritic cells
JM Blander et al.
NATURE (2006)
Low-dose intraperitoneal Freund's adjuvant:: Toxicity and immunogenicity in mice using an immunogen targeting amyloid-β peptide
J Oscherwitz et al.
VACCINE (2006)
Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency
J Kazzaz et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Effect of synthetic lipopeptides formulated in liposomes on the maturation of human dendritic cells (vol 42, pg 721, 2005)
S Espuelas et al.
MOLECULAR IMMUNOLOGY (2006)
Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen
R Audran et al.
INFECTION AND IMMUNITY (2005)
Effect of adjuvant on reactogenicity and long-term immunogenicity of the malaria Vaccine ICC-1132 in macaques
JAM Langermans et al.
VACCINE (2005)
Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children
KA Bojang et al.
VACCINE (2005)
Novel conjugates of epitope fusion peptides with CpG-ODN display enhanced immunogenicity and HIV recognition
P Daftarian et al.
VACCINE (2005)
Tuberculosis vaccine development; from mouse to man
S Reed et al.
MICROBES AND INFECTION (2005)
Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides
C Olive et al.
VACCINE (2005)
Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro
GL Morefield et al.
VACCINE (2005)
Recent advances with liposomes as pharmaceutical carriers
VP Torchilin
NATURE REVIEWS DRUG DISCOVERY (2005)
Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity
L Bungener et al.
VACCINE (2005)
Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery
CSW Chong et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Toward a definition of self: Proteomic evaluation of the class I peptide repertoire
HD Hickman et al.
JOURNAL OF IMMUNOLOGY (2004)
Dendrimers in drug research
U Boas et al.
CHEMICAL SOCIETY REVIEWS (2004)
Virosome and ISCOM vaccines against Newcastle disease: Preparation, characterization and immunogenicity
A Homhuan et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans
ID Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A central role for tissue-resident dendritic cells in innate responses
M Foti et al.
TRENDS IN IMMUNOLOGY (2004)
Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs
D Felnerova et al.
CURRENT OPINION IN BIOTECHNOLOGY (2004)
Distribution of adsorbed antigen in mono-valent and combination vaccines
GL Morefield et al.
VACCINE (2004)
Cutting edge: Different toll-like receptor agonists instruct dendritic cells to induce distinct th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-fos
S Agrawal et al.
JOURNAL OF IMMUNOLOGY (2003)
Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity
DJ Marciani
DRUG DISCOVERY TODAY (2003)
Pattern recognition molecules and innate immunity to parasites
DH McGuinness et al.
TRENDS IN PARASITOLOGY (2003)
The generalized endotoxic principle
U Seydel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines
WG Zeng et al.
JOURNAL OF IMMUNOLOGY (2002)
Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro
MEC Lutsiak et al.
PHARMACEUTICAL RESEARCH (2002)
QS-21 structure/function studies: effect of acylation on adjuvant activity
G Liu et al.
VACCINE (2002)
Induction of local innate immune responses and modulation of antigen uptake as mechanisms underlying the mucosal adjuvant properties of immune stimulating complexes (ISCOMS)
E Furrie et al.
VACCINE (2002)
Monophosphoryl lipid A activates both human dendritic cells and T cells
J Ismaili et al.
JOURNAL OF IMMUNOLOGY (2002)
Perspectives: towards a peptide-based vaccine against hepatitis C virus
IP Hunziker et al.
MOLECULAR IMMUNOLOGY (2001)
A Phase I safety and immunogenicity trial of UBI® microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects
JS Lambert et al.
VACCINE (2001)
Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins
DJ Marciani et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Adjuvants designed for veterinary and human vaccines
J Aucouturier et al.
VACCINE (2001)
New insights into endotoxin-induced activation of macrophages:: Involvement of a K+ channel in transmembrane signaling
R Blunck et al.
JOURNAL OF IMMUNOLOGY (2001)
Design of a minimal protein oligomerization domain by a structural approach
P Burkhard et al.
PROTEIN SCIENCE (2000)
The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments
K Mahnke et al.
JOURNAL OF CELL BIOLOGY (2000)
Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates
SK Kim et al.
VACCINE (2000)
Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity
DJ Marciani et al.
VACCINE (2000)
Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses
J Alexander et al.
JOURNAL OF IMMUNOLOGY (2000)
CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses
RM Vabulas et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
